OnCusp Therapeutics
Latest round
- Series A
Last raised
- Jan 2024
Total raised
- $125M
Investors
- 13
About OnCusp Therapeutics
Established in 2021 and based in New York, US, OnCusp Therapeutics operates as a biopharmaceutical company dedicated to providing oncology medicines. It has a sub-branch office in Shanghai. The co-Founder, Chairman and CEO of the company, Bin Yuan graduated from Columbia University and has worked in CStone Pharmaceuticals and Merck & Co. The CCO of the company, Tian Fu graduated from University of Connecticut and has worked in CStone Pharmaceuticals and Deloitte Touche Tohmatsu. The company has three product pipelines CUSP06, CUSP03, and CUSP02. CUSP06 is an ADC (Antibody–drug conjugate) targeting CDH6 (cadherin-6, is a type II classical cadherin from the cadherin superfamily), which is suitable for solid tumours. The CUSP03 and CUSP02 are suitable for haematologic and solid tumours. The CUPS06 is in Pre-Clinical period, and CUSP03 and CUSP02 are still in the development stage. The company will advance the clinical proof-of-concept of the company’s CDH6-targeting antibody drug conjugate CUSP06.
Who invested in OnCusp Therapeutics
13 investors across 2 rounds
See all investors in OnCusp Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about OnCusp Therapeutics
Who invested in OnCusp Therapeutics?
OnCusp Therapeutics has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has OnCusp Therapeutics raised?
OnCusp Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did OnCusp Therapeutics last raise money?
OnCusp Therapeutics's most recent round on record is a Series A, in Jan 2024.
What does OnCusp Therapeutics do?
Established in 2021 and based in New York, US, OnCusp Therapeutics operates as a biopharmaceutical company dedicated to providing oncology medicines.
Where is OnCusp Therapeutics headquartered?
OnCusp Therapeutics is headquartered in New York, US.
Which VCs invest in companies like OnCusp Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at OnCusp Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like OnCusp Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.